FrancophonIA/ELRC3.0 huggingface dataset:
English: Cardoreg 4 mg prolonged release tablets and associated names are white, round, biconvex tablets with bossing “DL” on one side.
Slovenian: Zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena so bele, okrogle, bikonveksne tablete z reliefnim napisom "DL" na eni strani.
English: Uncommon: alopecia, oedema of the face/general oedema Rare: rash, pruritus, purpura
Slovenian: Občasni: alopecija, edem obraza/splošni edem Redki: izpuščaj, pruritus, purpura
English: Administration of Cardoreg 4 mg prolonged release tablets and associated names in hypertensive patients causes a clinically significant reduction in blood pressure as a result of a reduction in systemic vascular resistance.
Slovenian: Uporaba zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena pri hipertenzivnih bolnikih povzroča klinično pomembno znižanje krvnega tlaka zaradi zmanjšanja sistemskega žilnega upora.
English: • History of oesophageal or gastrointestinal obstruction or decreased lumen diameter of the gastrointestinal tract
Slovenian: • eezofagealna ali gastrointestinalna obstrukcija v anamnezi ali zmanjšan premer lumna prebavil;
English: Cardoreg 4 mg prolonged release tablets and associated names should be used with care in patients with Diabetic Autonomic Neuropathy.
Slovenian: Zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena je treba pri bolnikih z diabetično avtonomno nevropatijo uporabljati previdno.
English: Uncommon: flushing, fever/shiver, paleness Rare: low body temperature in elderly
Slovenian: Občasni: vročinski oblivi, zvišanapovečana telesna temperatura/mrzlica, bledost Redki: nizka telesna temperatura pri starejših bolnikih
English: Administration of Cardoreg 4 mg prolonged release tablets and associated names to patients with prostatic hyperplasia results in a significant improvement in urodynamics and symptoms as a result of a selective blockade of alpha-adrenoceptors located in the prostatic muscular stroma, capsule and bladder neck.
Slovenian: Uporaba zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena pri bolnikih s prostatično hiperplazijo prostate pomembno izboljša urodinamiko in simptome zaradi selektivnega blokiranja alfa-adrenergičnih receptorjev v mišični stromi prostate, kapsuli in vratu mehurja.
English: Musculoskeletal, connective tissue and bone disorders: Uncommon: muscular pain, swelling of joints/arthralgia, muscle weakness
Slovenian: Bolezni mišično-skeletnega sistema, vezivnega tkiva in kosti: Občasni: bolečine v mišicah, otekanje sklepov/artralgija, šibkost mišic
English: If you stop taking Cardoreg 4 mg prolonged release tablets and associated names Do not stop taking your medicine without consulting your doctor.
Slovenian: Če ste prenehali jemati zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena Zdravila ne prenehajte jemati, dokler se ne posvetujete z zdravnikom.
English: One prolonged-release tablet contains 4,85 mg doxazosin mesilate corresponding to 4 mg doxazosin - The other ingredients are polyethylene oxide, microcrystalline cellulose, povidone, αtocopherol, colloidal anhydrous silica, sodium stearyl fumarate, methacrylic acid - ethyl acrylate co-polymer (1:1), macrogol, and titanium dioxide (E171).
Slovenian: - Pomožne snovi so polietilenoksid, mikrokristalna celuloza, povidon, α-tokoferol, koloidni brezvodni silicijev dioksid, natrijev stearilfumarat, kopolimer metakrilne kisline in etilakrilata (1 : 1), makrogol in titanov dioksid (E 171).
English: Common: accomodation disturbances Uncommon: lacrimation, photophobia Rare: blurred vision
Slovenian: Pogosti: motnje akomodacije Občasni: solzenje, fotofobija Redki: zamegljen vid
English: Cardoreg 4 mg prolonged release tablets and associated names can be used as sole agent or in combination with another medicinal product e.g. a thiazide diuretic, beta-adrenoceptor blocking agent, calcium antagonist or an ACE-inhibitor.
Slovenian: Zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena se lahko uporablja samostojno ali v kombinaciji z drugimi zdravili, npr. tiazidnimi diuretiki, blokatorji beta-adrenergičnih receptorjev, kalcijevimi antagonisti ali zaviralci ACE.
English: Respiratory, thoracic and mediastinal disorders: Common: dyspnoea, rhinitis
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora: Pogosti: dispneja, rinitis
English: After oral administration of therapeutic doses, doxazosin in Cardoreg 4 mg prolonged release tablets and associated names is well absorbed with peak blood levels gradually reached at 6 to 8 hours after dosing.
Slovenian: Po peroralnem jemanju terapevtskih odmerkov se doksazosin v zdravilu Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena dobro absorbira, najvišjenajvečje koncentracije v plazmi pa so postopoma dosežene v 6 do 8 urah po odmerjanju.
English: Common: giddiness, dizziness, oedema, orthostatic dysregulation Uncommon: postural hypotension, peripheral ischaemia, syncope Rare: cerebrovascular disturbances
Slovenian: Pogosti: omotica, vrtoglavica, edem, ortostatska disregulacija Občasni: posturalna hipotenzija, periferna ishemija, sinkopa Redki: cerebrovaskularne motnje
English: Uncommon: arrhythmia, angina pectoris, bradycardia, tachycardia, myocardial infarction
Slovenian: Pogosti: palpitacije, bolečine v prsnem košu Občasni: aritmija, angina pektoris, bradikardija, tahikardija, miokardni infarkt
English: At steady-state, the relative bioavailability of doxazosin from Cardoreg 4 mg prolonged release tablets and associated names compared to immediate release form was 54% at the 4 mg dose and 59% at the 8 mg dose.
Slovenian: V stanju dinamičnega ravnovesja je relativna biološka uporabnost doksazosina v zdravilu Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena 54 % relativne biološke uporabnosti doksazosina v tabletah s takojšnjim sproščanjem, pri odmerku 8 mg pa 59 %.
English: Essential hypertension
Slovenian: Esencialna hipertenzija.
English: In patients with hypertension, the decrease in blood pressure during treatment with Cardoreg 4 mg prolonged release tablets and associated names was similar in both the sitting and standing position.
Slovenian: Pri bolnikih s hipertenzijo je bilo med zdravljenjem z zdravilom Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena znižanje krvnega tlaka v sedečem in stoječem položaju podobno.
English: Do not use Cardoreg 4 mg prolonged release tablets and associated names after the expiry date which is stated on the carton and blister.
Slovenian: Zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na pretisnem omotu in škatli.
English: Some medicines may interact with Cardoreg 4 mg prolonged release tablets and associated names .
Slovenian: Nekatera zdravila lahko medsebojno delujejo z zdravilom Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena.
English: The majority of patients are controlled on the initial dose of 4 mg Cardoreg 4 mg prolonged release tablets and associated names .
Slovenian: Pri večini bolnikov za nadzor bolezni zadostuje začetni odmerek 4 mg zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena.
English: Common: frequent desire to micturate, increased micturation, delayed ejaculation Uncommon: incontinence, micturation disturbances, dysuria Rare: impotence, priapism
Slovenian: Pogosti: pogost občutek potrebe po uriniranju, pogostejše uriniranje, zapoznela ejakulacija Občasni: inkontinenca, motnje uriniranja, disurija Redki: impotenca, priapizem
English: Marketing Authorisation Holder and Manufacturer: [To be completed nationally]
Slovenian: Imetnik dovoljenja za promet z zdravilom in izdelovalec: [Izpolni država članica]
English: Common: muscle cramps, fatigue, malaise, headache, somnolence Uncommon: tremor, muscular stiffness Rare: paraesthesia
Slovenian: Pogosti: mišični krči, utrujenost, splošno slabo počutje, glavobol, somnolenca Občasni: tremor, otrdelost mišic
English: What Cardoreg 4 mg prolonged release tablets and associated names contains: - The active substance is doxazosin (as the mesilate).
Slovenian: Kaj vsebuje zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena: - Zdravilna učinkovina je doksazosin (v obliki mesilata).
English: Do not take Cardoreg 4 mg prolonged release tablets and associated names if you are pregnant or breast-feeding.
Slovenian: Zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena ne jemljite, če ste noseči ali če dojite.
English: Cardoreg 4 mg prolonged release tablets and associated names can be taken with or without food.
Slovenian: Zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena se lahko jemlje s hrano ali brez nje.
English: • Non-steroidal anti-inflammatory drugs (NSAIDs)
Slovenian: • nesteroidni antirevmatiki;
English: Throughout the recommended dosage range, Cardoreg 4 mg prolonged release tablets and associated names has only a minor or no effect on blood pressure in normotensive benign prostatic hyperplasia (BPH) patients.
Slovenian: Znotraj priporočenega intervala odmerkov ima zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena pri normotenzivnih bolnikih z benigno prostatično hiperplazijo prostate (BPH) le manjši učinek na krvni tlak ali pa ga sploh nima.
English: Common: constipation, dyspepsia Uncommon: anorexia, increased appetite, taste disturbances Rare: abdominal discomfort, diarrhoea, vomiting
Slovenian: Pogosti: zaprtje, dispepsija Občasni: anoreksija, povečan apetit, motnje okušanja Redki: neprijeten občutek v trebuhu, driska, bruhanje
English: Peak/trough ratio of Cardoreg 4 mg prolonged release tablets and associated names is less than half that of immediate release doxazosin tablets.
Slovenian: Razmerje največjih koncentracij in koncentracij pred naslednjim odmerkom pri zdravilu Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena je manjše kot polovica razmerja pri tabletah doksazosina s takojšnjim sproščanjem.
English: Cardoreg 4 mg prolonged release tablets and associated names works by relaxing muscle around the bladder exit and prostate gland, making it easier to pass urine.
Slovenian: Zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena deluje tako, da sprošča mišice okoli izvodila mehurja in prostate, kar olajša uriniranje.
English: Ear and labyrinth disorders: Uncommon: tinnitus
Slovenian: Ušesne bolezni, vključno z motnjami labirinta: Občasni: tinitus
English: If you take more Cardoreg 4 mg prolonged release tablets and associated names than you should
Slovenian: Če ste vzeli večji odmerek zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena, kot bi smeli
English: NAME OF THE MEDICINAL PRODUCT Cardoreg 4 mg prolonged release tablets and associated names {See Annex I] Doxazosin STATEMENT OF ACTIVE SUBSTANCE(S) Each prolonged-release tablet contains 4 mg of doxazosin (as mesilate).
Slovenian: Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena [glejte Dodatek I] 2 KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena tableta s podaljšanim sproščanjem vsebuje 4 mg doksazosina (v obliki mesilata).
English: Very rare side effects that may occur (in less than 1 in 10,000 people) are: - low white blood cells: low blood platelets, which may result in bruising or easy bleeding
Slovenian: Zelo redki neželeni učinki (ki se pojavijo pri manj kot 1 osebi od 10.000) so:
English: the CHMP has recommended the granting of the Marketing Authorisation(s) for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Cardoreg 4 mg prolonged release tablets and associated names (see Annex I).
Slovenian: je CHMP za Cardoreg 4 mg tablete s podaljšanim sproščanjem in z njim povezana imena (glejte Dodatek I) priporočil odobritev dovoljenj za promet z zdravilom, za katere so Povzetki glavnih značilnosti zdravila, označevanje in Navodila za uporabo opredeljeni v Dodatku III.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Cardoreg 4 mg prolonged release tablets and associated names [See Annex I] (Doxazosin)
Slovenian: NAVODILO ZA UPORABO Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena [glejte Dodatek I] (doksazosin)
English: Radioactivity was found to cross the placenta following oral administration of labelled doxazosin to pregnant rats.
Slovenian: Ugotovili so, da po peroralni uporabi označenega doksazosina pri brejih podganah, radioaktivnost prehaja v placento.
English: Uncommon: epistaxis, broncho spasms, cough, pharyngitis Rare: oedema of larynx
Slovenian: Občasni: epistaksa, bronhospazmi, kašelj, faringitis Redki: edem grla
English: One prolonged-release tablet contains 4 mg doxazosin (as mesilate).
Slovenian: Ena tableta s podaljšanim sproščanjem vsebuje 4,85 mg doksazosinijevega mesilata, kar ustreza 4 mg doksazosina.
English: Pharmacotherapeutic group: Alpha-adrenoceptor antagonists, ATC code: C02CA04
Slovenian: Oznaka ATC: C02CA04.
English: Patients treated with immediate release doxazosin tablets against hypertension can be transferred to Cardoreg 4 mg prolonged release tablets and associated names and the dose titrated upwards as needed, while maintaining effect and tolerability.
Slovenian: Bolniki, ki jemljejo tablete doksazosina s takojšnjim sproščanjem, lahko preidejo na zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena.
English: 3 HOW TO TAKE CARDOREG 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES
Slovenian: 3 KAKO JEMATI ZDRAVILO CARDOREG 4 MG TABLETE S PODALJŠANIM SPROŠČANJEM IN POVEZANA IMENA
English: 1 WHAT CARDOREG 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES IS AND WHAT IT IS USED FOR
Slovenian: 1 KAJ JE ZDRAVILO CARDOREG 4 MG TABLETE S PODALJŠANIM SPROŠČANJEM IN POVEZANA IMENA IN ZA KAJ GA UPORABLJAMO
English: Do not take Cardoreg 4 mg prolonged release tablets and associated names
Slovenian: Ne jemljite zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena:
English: Patients with hepatic impairment: Cardoreg 4 mg prolonged release tablets and associated names should be given with particular caution to patients with evidence of impaired liver function.
Slovenian: Bolniki z jetrno okvaro: Bolnikom z jetrno okvaro je treba zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena dajati posebno previdno.
English: Take special care with Cardoreg 4 mg prolonged release tablets and associated names
Slovenian: Bodite posebno pozorni pri jemanju zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena:
English: Always take Cardoreg 4 mg prolonged release tablets and associated names exactly as your doctor has told you.
Slovenian: Pri jemanju zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena natančno upoštevajte zdravnikova navodila.
English: Cardoreg 4 mg prolonged release tablets and associated names should be administered with caution in patients with signs of mild to moderate hepatic impairment (see section 5.2).
Slovenian: Pri bolnikih z manjšo do zmerno jetrno okvaro je treba zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena odmerjati previdno (glejte poglavje 5.2).
English: Hepatobiliary disorders: Rare: icterus, increased liver values
Slovenian: Bolezni jeter, žolčnika in žolčevodov: Redki: ikterus, zvišanepovečane vrednosti jetrnih encimov
English: 2 BEFORE YOU TAKE CARDOREG 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES
Slovenian: 2 KAJ MORATE VEDETI, PREDEN BOSTE VZELI ZDRAVILO CARDOREG 4 MG TABLETE S PODALJŠANIM SPROŠČANJEM IN POVEZANA IMENA
English: 5 HOW TO STORE CARDOREG 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES
Slovenian: 5 SHRANJEVANJE ZDRAVILA CARDOREG 4 MG TABLETE S PODALJŠANIM SPROŠČANJEM IN POVEZANA IMENA
English: Cardoreg 4 mg prolonged release tablets and associated names can cause drowsiness.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena lahko povzroči dremavost.
English: Cardoreg 4 mg prolonged release tablets and associated names
Slovenian: Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena [glejte Dodatek I] doksazosin
English: Cardoreg 4 mg prolonged release tablets and associated names may be used in benign prostatic hyperplasia (BPH) patients who are either hypertensive or normotensive, as the blood pressure changes in normotensive patients are clinically insignificant.
Slovenian: Spremembe krvnega tlaka pri normotenzivnih bolnikih so klinično nepomembne, zato se lahko zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena uporablja pri hipertenzivnih in tudi pri normotenzivnih bolnikih z benigno prostatično hiperplazijo prostate (BPHbenign prostatic hyperplasia).
English: What Cardoreg 4 mg prolonged release tablets and associated names is and what it is used for 2.
Slovenian: Kaj je zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena in za kaj ga uporabljamo
English: Taking Cardoreg 4 mg prolonged release tablets and associated names with food and drink Cardoreg 4 mg prolonged release tablets and associated names can be taken with or after food.
Slovenian: Jemanje zdravila Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena skupaj s hrano in pijačo
English: How to take Cardoreg 4 mg prolonged release tablets and associated names 4.
Slovenian: Kako jemati zdravilo Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena Možni neželeni učinki
English: Metabolism and nutrition disorders: Uncommon: thirst, hypokalaemia, gout Rare: hypoglycaemia Very rare: increase in serum urea.
Slovenian: Redki: hipoglikemija Zelo redki: zvišanepovečanje vrednosti uree v serumu
English: Alternatively, breast-feeding must be stopped, if treatment with Cardoreg 4 mg prolonged release tablets and associated names is unavoidable.
Slovenian: Če je zdravljenje z zdravilom Cardoreg 4 mg tablete s podaljšanim sproščanjem in povezana imena neizogibno, je treba dojenje prekiniti.
English: This overview was last updated in March 2018.
Slovenian: Ta pregled je bil nazadnje posodobljen marca 2018.
English: SevoFlo (sevoflurane)
Slovenian: SevoFlo (sevofluran)
English: EMA/CVMP/92087/2007 EMEA/V/C/000072
Slovenian: EMEA/CVMP/92087/2007 EMEA/V/C/000072
English: Further information on SevoFlo can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Slovenian: Nadaljnje informacije o zdravilu SevoFlo so na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: Together, these combined actions result in loss of consciousness.
Slovenian: Združena učinka povzročita izgubo zavesti.
English: SevoFlo (sevoflurane) EMA/CVMP/92087/2007
Slovenian: SevoFlo (sevofluran) EMA/CVMP/92087/2007
English: The European Medicine's Agency decided that SevoFlo's benefits are greater that its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi zdravila SevoFlo večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: SevoFlo must not be given to animals with a genetic susceptibility to malignant hyperthermia.
Slovenian: Zdravilo SevoFlo se ne sme dajati živalim z gensko občutljivostjo na maligno hipertermijo.
English: Other information about SevoFlo
Slovenian: Druge informacije o zdravilu SevoFlo
English: Pregnant and breast-feeding women must not come into contact with the product and they should also avoid operating rooms and animal recovery areas where the product is being used or has recently been used.
Slovenian: Nosečnice in doječe matere ne smejo priti v stik z zdravilom, zato se morajo izogibati operacijskim sobam in prostorom za prebujanje živali, v katerih se zdravilo uporablja oziroma je bilo uporabljeno pred nedavnim.
English: What benefits of SevoFlo have been shown in studies?
Slovenian: Kakšne koristi je zdravilo SevoFlo izkazalo v študijah?
English: Why is SevoFlo authorised in the EU?
Slovenian: Zakaj je zdravilo SevoFlo odobreno v EU?
English: SevoFlo is a general anaesthetic for dogs and cats.
Slovenian: Zdravilo SevoFlo je splošni anestetik za pse in mačke.
English: Sevoflurane mimics the action of GABA, a substance that naturally reduces brain activity, and blocks the action of glutamate, which stimulates the activity of the brain.
Slovenian: Sevofluran posnema delovanje snovi GABA, ki naravno zavira možgansko dejavnost, in zmanjšuje delovanje glutamata, ki spodbuja delovanje možganov.
English: The dog or cat breathes in the gas mixture, which causes it to become unconscious.
Slovenian: Pes ali mačka vdihava to plinsko mešanico, kar povzroči izgubo zavesti.
English: What are the risks associated with SevoFlo?
Slovenian: Kakšna tveganja so povezana z zdravilom SevoFlo?
English: In addition, SevoFlo has been commonly used off-label (use that is not officially authorised) as an anaesthetic for cats for more than 10 years and therefore its use in cats is considered to be ‘well-established'.
Slovenian: Poleg tega se zdravilo Sevoflo kot anestetik za mačke nenamensko uporablja (brez uradnega dovoljenja) več kot 10 let, zato je njegova uporaba pri mačkah dobro uveljavljena.
English: The effectiveness of SevoFlo was comparable to isoflurane.
Slovenian: Učinkovitost zdravila SevoFlo je bila primerljiva z izofluranom.
English: SevoFlo is given using specialised anaesthetic equipment, usually in a carefully controlled gas mixture including oxygen.
Slovenian: Zdravilo SevoFlo se daje s pomočjo specializirane opreme za anestezijo, običajno v obliki natančno regulirane plinske mešanice, v kateri je tudi kisik.
English: An overview of SevoFlo and why it is authorised in the EU
Slovenian: Pregled zdravila SevoFlo in zakaj je odobreno v EU
English: This is a rare life-threatening condition usually triggered by exposure to certain general anaesthetics that is associated with muscle spasm and very high body temperatures.
Slovenian: To je redko, življenjsko nevarno stanje, ki ga lahko povzroči izpostavljenost nekaterim splošnim anestetikom ter je povezano z mišičnimi krči in zelo visoko telesno temperaturo.
English: When a dog or cat is given a mixture of oxygen and sevoflurane to breathe, the sevoflurane is inhaled into its lungs and is carried by the blood into the brain.
Slovenian: Ko pes ali mačka vdihne mešanico kisika in sevoflurana, ta preide v pljuča in se po krvi prenese v možgane.
English: If a person accidentally inhales sevoflurane vapour, this may cause symptoms such as shivering, nausea, headache, low blood pressure, decreased heart rate and even reduced breathing.
Slovenian: Če oseba nenamerno vdihava hlape sevoflurana, lahko to povzroči simptome, kot so tresavica, siljenje na bruhanje, glavobol, nizek krvni tlak, zmanjšan srčni utrip in celo upočasnjeno dihanje.
English: Care must therefore be taken when handling SevoFlo: any spillage must be removed immediately, the vapour must not be inhaled, and any contact with the product by mouth must be avoided.
Slovenian: Pri ravnanju z zdravilom SevoFlo je zato potrebna posebna pozornost: morebitno razlito zdravilo je treba takoj odstraniti, hlapi se ne smejo vdihavati, prav tako pa se je treba izogibati vsakršnemu peroralnemu stiku z zdravilom.
English: What is SevoFlo and what is it used for?
Slovenian: Kaj je zdravilo SevoFlo in za kaj se uporablja?
English: The most common side effects with SevoFlo, which may affect more than 1 in 10 animals, are low blood pressure, rapid breathing, muscle tenseness, excitation, a temporary inability to breathe, small muscle twitches and vomiting.
Slovenian: Najpogostejši neželeni učinki pri uporabi zdravila SevoFlo, ki lahko prizadenejo več kot 1 žival od 10, so nizek krvni tlak, hitro dihanje, napetost v mišicah, razdraženost, začasna nezmožnost dihanja, majhne kontrakcije mišic in bruhanje.
English: In case of accidental contact with the skin or eyes, or for more information, the package leaflet should be consulted.
Slovenian: Če pride do nenamernega stika s kožo ali očmi ali če želite več informacij, si preberite navodilo za uporabo.